GlassScriptPhysician profile
Aaron M Ricca
NPI 1801274295
$4,751.26
in general payments reported to CMS, 2019-2025
15 companies · $1,104 in 2025
The $1,104 reported for 2025 was more than what 75% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.68 · 2021: $454 · 2022: $1,171 · 2023: $1,478 · 2024: $445 · 2025: $1,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,026.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $859.51 | 2021-2025 | Vabysmo |
| Alcon Vision LLC | $816.47 | 2021-2025 | Constellation, Clareon, Unity |
| Apellis Pharmaceuticals, INC. | $740.18 | 2022-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $503.78 | 2021-2025 | Eylea Hd, Eylea |
| Astellas Pharma US INC | $480.16 | 2023-2025 | Izervay |
| Regeneron Pharmaceuticals, INC. | $257.15 | 2022-2024 | Eylea Hd, Eylea |
| Eyepoint US, INC. | $178.12 | 2021-2022 | |
| Glaukos Corporation | $170.90 | 2025 | Idosetr |
| Abbvie INC. | $166.19 | 2023-2025 | |
| Alcon Research LLC | $131.92 | 2025 | |
| Biogen, INC. | $110.42 | 2023-2024 | Byooviz |
| The Cameron-Ehlen Group, INC. | $99.68 | 2019 | |
| Optos, INC. | $86.66 | 2022 | |
| Alimera Sciences, INC. | $85.85 | 2022-2024 | Iluvien, Yutiq |
| Ani Pharmaceuticals, INC. | $64.27 | 2024-2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Ricca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.